Skip to content

Clinical trial to verify effectiveness of VR table tennis program for people with Parkinson disease

Clinical trial on the effectiveness and feasibility of a VR table tennis program in people with Parkinson disease - Clinical trials on VR table tennis program for Parkinson disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049144
Enrollment
4
Registered
2022-11-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease

Interventions

Rehabilitation combining VR table tennis rehabilitation with occupational and speech therapies is provided to study participants. The VR model and software used for the study is the Oculus Quest 2 and
after five minutes break, the patient trains in match mode for 15 minutes. During training in match mode, breaks should be taken at the patient&#39
s request or at the discretion of the assisting healthcare professional. Patients at risk of falling due to balance problems can perform the program in a sitting position. After training with VR table

Sponsors

Murakami Karindoh Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. People who fulfil the clinical diagnostic criteria as Probable Parkinson disease 2. People with Parkinson disease with severity of Hohen & Yahr I-III 3. Any gender

Exclusion criteria

Exclusion criteria: 1. People with Parkinsonian syndrome other than Parkinson disease 2. People with cognitive impairment (MoCA-J less than 20 points) 3. People with suffering from inner ear disorders that may cause VR sickness 4. People who have difficulty continuing VR for more than 10 minutes due to VR sickness during the VR experience conducted beforehand 5. People who have regularly played table tennis within 3 months before study participation 6. People who are deemed unsuitable by the principal investigator or a sub-investigator

Design outcomes

Primary

MeasureTime frame
MDS-UPDRS part III

Secondary

MeasureTime frame
1. MDS-UPDRS part I, II, IV 2. Montreal Cognitive Assessment 3. Self-rating Depression Scale 4. Apathy Evaluation Scale 5. 3m up & go test 6. 10m gait 7. Parkinson's Disease Questionnaire 8. System Usability Scale

Countries

Japan

Contacts

Public ContactShinsuke Fujioka

Murakami Karindoh Hospital Neurology

shinsuke@cis.fukuoka-u.ac.jp092-811-3331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026